Dhanuka Agritech Limited

BSE:507717 Rapport sur les actions

Capitalisation boursière : ₹48.6b

Dhanuka Agritech Résultats passés

Passé contrôle des critères 2/6

Dhanuka Agritech a connu une croissance annuelle moyenne de ses bénéfices de 8.2%, tandis que le secteur Chemicals a vu ses bénéfices augmenter de en hausse à 6.2% par an. Les revenus ont augmenté de en hausse à un taux moyen de 8.7% par an. Le rendement des capitaux propres de Dhanuka Agritech est 17.1% et ses marges nettes sont de 14.2%.

Informations clés

8.23%

Taux de croissance des bénéfices

9.16%

Taux de croissance du BPA

Chemicals Croissance de l'industrie17.68%
Taux de croissance des recettes8.72%
Rendement des fonds propres17.08%
Marge nette14.22%
Dernière mise à jour des bénéfices31 Mar 2026

Mises à jour récentes des performances passées

Recent updates

Mise à jour du récit • Jun 15

507717: Share Buyback And Overseas Expansion Will Support Future Upside Potential

Analysts have kept their price target for Dhanuka Agritech broadly steady at around ₹1,414 per share. This reflects only marginal tweaks to assumptions on discount rate, long term revenue growth, profit margin and future P/E, rather than any change in their core view on the company.
Mise à jour du récit • Jun 01

507717: Share Buyback Will Support Future Upside Confidence

Analysts have slightly reduced their price target on Dhanuka Agritech, with fair value moving from about ₹1,439.57 to ₹1,414.38 as they update assumptions around revenue growth, profit margins and forward P/E multiples. What's in the News The board will meet on May 19, 2026, to consider audited financial results for the quarter and financial year ended March 31, 2026; introduce and consider Employee Stock Option Scheme 2026, Employee Stock Appreciation Rights 2026, and Restricted Stock Unit Plan 2026; and address other matters.
Mise à jour du récit • May 03

507717: Upcoming Director Appointment Will Support Future Upside Confidence

Analysts have nudged their price target on Dhanuka Agritech slightly higher, with fair value moving from ₹1,426.00 to about ₹1,439.57, citing updated assumptions around the discount rate, revenue growth, profit margins and future P/E. What's in the News A postal ballot based Special or Extraordinary Shareholders Meeting is scheduled for March 19, 2026, in India (Key Developments).
Mise à jour du récit • Apr 18

507717: Upcoming Governance And Earnings Dates Will Support Future Upside Confidence

Analysts have trimmed their price target on Dhanuka Agritech slightly from ₹1,438.50 to ₹1,426.00, reflecting updated assumptions around the discount rate, revenue growth, profit margin, and forward P/E. What's in the News Special or Extraordinary Shareholders Meeting scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (company filing).
Mise à jour du récit • Apr 03

507717: Upcoming Governance And Earnings Dates Will Support Upside Confidence

Analysts have kept their price target for Dhanuka Agritech steady at around ₹1,438, reflecting largely unchanged views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Dhanuka Agritech has scheduled a Special or Extraordinary Shareholders Meeting via postal ballot in India on March 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (Key Developments).
Mise à jour du récit • Mar 19

507717: Upcoming Meetings Will Reinforce Confidence In Sustained Upside Potential

Analysts have kept the price target for Dhanuka Agritech broadly steady at around ₹1,438, with only minor model tweaks to the discount rate and the assumed future P/E driving the small change. What's in the News A Special or Extraordinary shareholders meeting is scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an independent director for a first term of 5 years (company filing).
Mise à jour du récit • Mar 05

507717: Upcoming Meetings Will Support Confidence In Long-Term Upside Potential

Analysts have maintained their ₹1,438.50 price target for Dhanuka Agritech and made only minor adjustments to their assumptions on discount rate, revenue growth, profit margin and future P/E. These limited changes suggest that their overall valuation framework remains broadly consistent with earlier assessments.
Nouveau récit • Feb 21

Rural Distribution And Biostimulant Tailwinds Will Support A Stronger Long Term Outlook

Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection and allied products to farmers across major agricultural regions in India. What are the underlying business or industry changes driving this perspective?
Mise à jour du récit • Feb 19

507717: Upcoming Board And Shareholder Meetings Will Support Long-Term Upside Potential

Analysts have revised their price target on Dhanuka Agritech from ₹1,571.75 to ₹1,438.50, reflecting updated assumptions around the discount rate, expected revenue growth, profit margin and future P/E multiples. What's in the News Dhanuka Agritech has scheduled a Board Meeting on Feb 05, 2026, at 13:00 Indian Standard Time to consider and approve the financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
Nouveau récit • Feb 06

Dahej Ramp Up Risks And Regulatory Setbacks Will Eventually Support A Stronger Business

Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection products and related offerings to farmers across major agricultural regions. What are the underlying business or industry changes driving this perspective?
Mise à jour du récit • Feb 04

507717: Stable Assumptions And Upcoming Results Will Support Long-Term Upside Potential

Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,571.75, citing broadly consistent assumptions for the discount rate, revenue growth, profit margin and future P/E in their refreshed model. What's in the News Dhanuka Agritech has scheduled a board meeting on Feb 05, 2026.
Mise à jour du récit • Jan 21

507717: Higher Margin Outlook Will Support Long-Term Upside Potential

Analysts have trimmed their price target for Dhanuka Agritech by ₹35 to ₹1,571.75. This reflects updated views on slightly lower revenue growth assumptions, a modestly higher discount rate, and a small adjustment to future P/E expectations, partly offset by a marginally higher profit margin outlook.
Mise à jour du récit • Jan 06

507717: Nagpur Plant Land Purchase Will Support Long-Term Upside Potential

Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,606.75, with only minor tweaks to inputs such as the discount rate, revenue growth, profit margin, and future P/E assumptions guiding their view. What's in the News Board meeting scheduled on Oct 31, 2025 at 11:00 Indian Standard Time to review and approve financial results for the quarter and half year ended Sep 30, 2025 (company filing).
Mise à jour du récit • Dec 16

507717: Nagpur Formulation Plant Expansion Will Drive Long-Term Upside Potential

Analysts have nudged their fair value estimate for Dhanuka Agritech down slightly from ₹1,638 to about ₹1,607 per share, reflecting tempered revenue growth expectations, partially offset by a modestly higher projected profit margin and a slightly lower assumed future P E multiple. What's in the News Board meeting scheduled on October 31, 2025, at 11:00 IST to review financial results for the quarter and half year ended September 30, 2025 (company filing) Board to consider purchase of land in Nagpur, Maharashtra, for setting up a new formulation plant, indicating planned capacity expansion (company filing) Outcome of the October 31, 2025 board meeting expected to provide clarity on near term growth, capex, and margin trajectory (company filing) Valuation Changes The fair value estimate was reduced slightly from ₹1,638 to about ₹1,607 per share, reflecting marginally softer assumptions.
Mise à jour du récit • Dec 02

507717: Upcoming Nagpur Plant And Board Actions Will Fuel Long-Term Momentum

Analysts have maintained their fair value estimate for Dhanuka Agritech at ₹1,638, citing stable projections for growth and profitability despite minor adjustments in underlying assumptions. What's in the News Dhanuka Agritech will hold a Board Meeting on October 31, 2025, at 11:00 Indian Standard Time (Board Meeting announcement).
Mise à jour du récit • Nov 17

507717: New Formulation Plant Decision Will Drive Next Wave Of Expansion

Analysts have lowered their price target for Dhanuka Agritech from ₹1,779.88 to ₹1,638.00. This reflects tempered expectations for future revenue growth and profit margins.
Mise à jour du récit • Nov 03

507717: New Nagpur Plant And Higher Margins Will Drive Future Upside

Analysts have revised their price target for Dhanuka Agritech downward from ₹1,875 to ₹1,779.88. This adjustment reflects updated projections in revenue growth and profit margins, as well as a slightly reduced future valuation multiple.
Mise à jour du récit • Sep 05

Improved Monsoon Trends And Capacity Expansion Will Drive Agrochemicals Demand

With both the discount rate and future P/E essentially unchanged, analysts maintained Dhanuka Agritech’s fair value at ₹1875. What's in the News Board meeting scheduled to consider and approve financial results for the quarter ended 30 June, 2025.
User avatar
Nouveau récit • Feb 09

Acquiring Rights To Iprovalicarb And Triadimenol Will Open International Markets

International expansion and product innovation could boost revenue through new market entry, geographic diversification, and premium pricing for unique solutions.

Ventilation des recettes et des dépenses

Comment Dhanuka Agritech gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.

Historique des gains et des recettes

BSE:507717 Recettes, dépenses et bénéfices (INR Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
31 Mar 2620,1982,8721,8980
31 Dec 2519,7852,6501,9930
30 Sep 2520,1382,8001,9670
30 Jun 2520,6993,0361,9550
31 Mar 2520,3522,9701,9170
31 Dec 2419,6142,8051,8810
30 Sep 2419,1942,7081,8580
30 Jun 2418,8312,5501,8320
31 Mar 2417,5852,3911,7450
31 Dec 2317,6152,4541,6120
30 Sep 2317,5162,4611,5220
30 Jun 2316,7662,1731,4260
31 Mar 2317,0022,3351,4420
31 Dec 2216,4732,2261,3990
30 Sep 2216,1082,1911,3870
30 Jun 2215,0672,0941,3800
31 Mar 2214,7782,0891,3520
31 Dec 2114,3502,0311,3240
30 Sep 2113,7382,0071,2930
30 Jun 2113,7742,0741,2930
31 Mar 2113,8752,1061,3140
31 Dec 2013,3952,0091,2370
30 Sep 2013,1531,8861,2340
30 Jun 2012,7491,7851,1310
31 Mar 2011,2011,4131,1280
31 Dec 1910,8521,2911,1850
30 Sep 1910,3051,1601,1560
30 Jun 1910,1181,1111,1630
31 Mar 1910,0581,1261,1740
31 Dec 189,9821,1451,2550
30 Sep 1810,0291,2851,2940
30 Jun 189,6761,2621,2530
31 Mar 189,6261,2621,2460
31 Dec 179,2651,2011,1890
30 Sep 179,1681,1831,1560
30 Jun 178,8121,1561,1320
31 Mar 178,8331,2191,1180
31 Dec 168,8861,2371,1520
30 Sep 168,8571,1961,1020
30 Jun 168,4691,0811,0610
31 Mar 168,2891,0731,0030
31 Dec 158,1161,0071,48310
30 Sep 157,8501,0026840
30 Jun 157,9771,0426620

Des revenus de qualité: 507717 a des bénéfices de haute qualité.

Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de 507717 sont inférieures à celles de l'année dernière 507717. (14.2%) sont inférieures à celles de l'année dernière (14.6%).

Analyse des flux de trésorerie disponibles par rapport aux bénéfices

Analyse de la croissance passée des bénéfices

Tendance des revenus: Les bénéfices de 507717 ont augmenté de 8.2% par an au cours des 5 dernières années.

Accélération de la croissance: 507717 a connu une croissance négative de ses bénéfices au cours de l'année écoulée, elle ne peut donc pas être comparée à sa moyenne sur 5 ans.

Bénéfices par rapport au secteur d'activité: 507717 a enregistré une croissance négative de ses bénéfices ( -3.3% ) au cours de l'année écoulée, ce qui rend difficile la comparaison avec la moyenne du secteur Chemicals ( 12.8% ).

Rendement des fonds propres

ROE élevé: Le retour sur capitaux propres de 507717 ( 17.1% ) est considéré comme faible.

Rendement des actifs

Rendement des capitaux employés

Découvrir des entreprises performantes dans le passé

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/06/16 14:17
Cours de l'action en fin de journée2026/06/16 00:00
Les revenus2026/03/31
Revenus annuels2026/03/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Dhanuka Agritech Limited est couverte par 17 analystes. 7 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
null null360 ONE Capital Market Private Limited
null nullAnand Rathi Shares and Stock Brokers Limited
Himanshu BinaniAnand Rathi Shares and Stock Brokers Limited